Testing a new smallpox and mpox vaccine in the Democratic Republic of the Congo
Part of Infections clinical trials.
This study tests a new vaccine designed to protect against smallpox and mpox. It aims to see if the vaccine is safe and triggers a good immune response in people aged 2 to 45.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 2 and 45 years old.
- You must be in good general health.
- You must never have had a smallpox or mpox vaccination.
- You must never have had monkeypox, cowpox, or vaccinia virus infection.
- If you can become pregnant, you must use effective contraception and not be pregnant or breastfeeding.
- You must live in the study area and be able to attend all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
This study follows people who are getting a booster dose of the MVA-BN vaccine, which is used to protect against mpox. The goal is to see how the booster works and monitor any side effects.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
Hear when a new Monkeypox (Mpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.